XNK receives certificate of GMP compliance of a manufacturer from the Medical Products Agency

XNK Therapeutics today announced that it has received a GMP manufacturing license and a certificate of GMP compliance from the Swedish Medical Products Agency, which means that the company can produce at scale for its planned clinical studies.

“We are very happy to receive this license. It is an important milestone for XNK, and we are now well positioned for significant value creation with three to four potential phase I/II readouts in our pipeline over the coming three years. The in-house GMP facility provides us with valuable capacity, flexibility and control over our clinical manufacturing which brings competitive advantages going forward. In addition, the close collaboration and proximity between manufacturing and research & innovation ensures efficient process development and organizational learning,” said Johan Liwing, CEO, XNK Therapeutics.

The building phase of the company’s new GMP clean room facility was completed in September 2022. The GMP facility comprises approximately 350 square meters and is located at XNK in the Novum Research Park, co-located with the Karolinska Institutet and the Karolinska University Hospital in Huddinge, Sweden.

“I am proud of the team which has worked hard over the past 18 months to build and validate our new GMP facility and a regulatory compliant Pharmaceutical Quality System. This will enable us of aseptic production of ATMPs for future clinical trials. This is an important step in the company’s ambitious growth plan to enable further larger clinical trials with our natural killer cell-based therapies,” said Linda Brink, Head of QA at XNK Therapeutics.

Flemingsberg Science Foundation welcomes Uroš Mićić as the new Community Manager

In December last year, the Flemingsberg Science Foundation was granted funding from the European Regional Development Fund to establish itself as a key player in Life Science with the launch of the "Cluster Engine Life Science Flemingsberg" project. Meet Uroš Mićić, the foundation's new Community Manager, who will work on developing the Life Science cluster in Flemingsberg.

Master the Art of Pitching – Elevate Your Startup Game

Are you an entrepreneur or innovator with a game-changing startup idea? Want to communicate it with confidence, clarity, and impact? Join Venture Cup and Flemingsberg Science Foundation for a high-energy, hands-on pitch workshop led by Malcolm Larri, a renowned pitch coach who has trained founders across the Nordics and beyond.

The Flemingsberg Science Foundation welcomes Natasha Bank as the new Cluster Manager.

In December last year, the Flemingsberg Science Foundation was granted funding from the European Regional Development Fund to establish itself as a key player in Life Science with the launch of the project “Cluster Engine Life Science Flemingsberg.” Natasha Bank, the foundation’s rising star who will lead the project to success, shares more about herself and her new role.